ROCHESTER, N.Y. — PharmaSmart International and Microlife will offer an integrated assessment of cardiovascular health risk factors to healthcare providers under a new partnership between the companies.
PharmaSmart and Microlife said they would bring together their technologies, market presence and expertise to provide pharmacists, payers and providers with an integrated patient diagnostic screening system, with combined screening venues to include community pharmacies, workplaces, homes, medical clinics and ambulatory monitoring. PharmaSmart is a manufacturer of health kiosks and related services that works with pharmacy retailers, workplaces, military bases, health clinics and hospitals in North America. Microlife, based in Taiwan, manufactures medical measurement devices for clinical and home use.
The partnership will include an integration of Microlife’s Watch BP product line into PharmaSmart’s BPT Suite data network, which in turn delivers patient-specific biometrics electronically to providers and patients through electronic health record integration and to patients through mobile devices and Web portals.
“Millions of Americans are walking around with hypertension, atrial fibrillation and other risk factors that are undetected or misdiagnosed,” PharmaSmart president Fred Sarkis said. “During our exploratory discussions, we found that Microlife and PharmaSmart are aligned in our commitment to improving the quality and quantity of diagnostic measurements globally. Working together, we can offer the healthcare system a multitiered solution for population screening that just doesn’t exist today.”